Table of Contents
The role of Authorized Agent Responsibilities is critical for foreign Pharmaceutical companies seeking to register, Import, and market Drugs in India while ensuring full regulatory compliance with CDSCO requirements.
An authorized agent acts as the legal representative in India, bridging communication between the foreign manufacturer and Indian regulatory authorities throughout the product lifecycle.
Under Indian regulations, foreign manufacturers must appoint an authorized agent to interact with CDSCO for approvals and compliance.
These agents often act as Drug registration holder, ensuring documentation accuracy and regulatory submissions.
They are legally accountable for maintaining compliance under the Drugs and Cosmetics Act and rules and NDCT Rules.
The authorized agent’s duties extends beyond registration into continuous regulatory oversight.
Authorized agents must ensure that all imported Drugs comply with Indian standards and post-approval obligations.
These duties ensure uninterrupted market access and regulatory alignment.
Authorized agents are responsible for fulfilling Indian Pharmacovigilance requirements, particularly for imported Drugs.
They must establish systems for safety monitoring and ensure timely ADR reporting for CDSCO compliance.
Failure to comply may lead to regulatory actions or suspension of licenses.
The authorized agent plays a crucial role in product recall processes.
They must act promptly in case of safety concerns, quality defects, or regulatory directives.
This ensures patient safety and regulatory compliance during critical situations.
Authorized agents must maintain comprehensive records related to import, distribution, safety, and compliance.
These records are essential during CDSCO inspections and audits.
| Document Type | Purpose | Regulatory Importance |
| Import License | Legal authorization | Mandatory for market entry |
| Registration Certificate | Product approval | Proof of compliance |
| ADR Records | Safety monitoring | Pharmacovigilance compliance |
| PSUR Reports | Periodic safety updates | Risk-benefit evaluation |
| Recall Records | Product withdrawal tracking | Patient safety |
Table 1

Figure 1
Authorized agents must manage complex regulatory expectations while coordinating with multiple stakeholders.
Challenges include evolving regulations, tight reporting timelines, and ensuring consistency between global and Indian compliance systems.
However, strong regulatory expertise and robust systems can mitigate these challenges effectively.
Authorized agents play a pivotal role in ensuring regulatory compliance and market continuity for imported Drugs in India.
In conclusion, authorized agent is essential for maintaining compliance, ensuring drug safety, and enabling smooth market access within India’s regulated pharmaceutical environment.
What a Revised Schedule M raises GMP standards in India, what has changed for manufacturers, and how large firms and MSMEs can prepare for Compliance and CDSCO inspections. Revised Schedule M is the b..
A practical comparison of CDSCO vs FDA vs EMA, explaining how each regulator’s Drug approval process differs and why one Drug needs separate approvals in India, the US and Europe. A Drug approve..
A quick guide on the Class A & B Medical Device manufacturing license — covering State FDA rules, Form MD-3/MD-5, fees, and timelines for manufacturers. Every manufacturer entering India’s..